Peter Wonerow

1.4k total citations
24 papers, 1.1k citations indexed

About

Peter Wonerow is a scholar working on Molecular Biology, Hematology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Peter Wonerow has authored 24 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Hematology and 8 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Peter Wonerow's work include Platelet Disorders and Treatments (8 papers), Thyroid Disorders and Treatments (8 papers) and Thyroid Cancer Diagnosis and Treatment (5 papers). Peter Wonerow is often cited by papers focused on Platelet Disorders and Treatments (8 papers), Thyroid Disorders and Treatments (8 papers) and Thyroid Cancer Diagnosis and Treatment (5 papers). Peter Wonerow collaborates with scholars based in Germany, United Kingdom and United States. Peter Wonerow's co-authors include Steve P. Watson, Dagmar Führer, Ralf Paschke, Dagmar Führer‐Sakel, Andrew C. Pearce, Werner A. Scherbaum, Ralf Paschke, David J. Vaux, Naoki Asazuma and Barbara Trülzsch and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Clinical Endocrinology & Metabolism and Oncogene.

In The Last Decade

Peter Wonerow

24 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Wonerow Germany 19 455 391 342 156 119 24 1.1k
Consuelo González‐Manchón Spain 18 536 1.2× 290 0.7× 303 0.9× 198 1.3× 34 0.3× 61 1.2k
J W Voss United States 8 575 1.3× 585 1.5× 83 0.2× 58 0.4× 53 0.4× 10 1.3k
Seema Mohamed United States 10 424 0.9× 388 1.0× 36 0.1× 141 0.9× 40 0.3× 15 897
Angela Russo United States 20 537 1.2× 89 0.2× 151 0.4× 53 0.3× 45 0.4× 38 1.0k
Ruoqian Shen United States 18 593 1.3× 111 0.3× 60 0.2× 47 0.3× 135 1.1× 27 1.2k
Laura A. Maile United States 28 874 1.9× 541 1.4× 37 0.1× 306 2.0× 43 0.4× 48 1.5k
Mousumi Majumdar United States 9 585 1.3× 26 0.1× 157 0.5× 134 0.9× 66 0.6× 9 872
Chenzhong Fu United States 10 374 0.8× 36 0.1× 51 0.1× 171 1.1× 52 0.4× 11 733
Pavel N. Pichurin United States 23 429 0.9× 918 2.3× 70 0.2× 26 0.2× 66 0.6× 62 1.8k
M M Thompson United States 10 730 1.6× 39 0.1× 48 0.1× 254 1.6× 59 0.5× 10 1.2k

Countries citing papers authored by Peter Wonerow

Since Specialization
Citations

This map shows the geographic impact of Peter Wonerow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Wonerow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Wonerow more than expected).

Fields of papers citing papers by Peter Wonerow

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Wonerow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Wonerow. The network helps show where Peter Wonerow may publish in the future.

Co-authorship network of co-authors of Peter Wonerow

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Wonerow. A scholar is included among the top collaborators of Peter Wonerow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Wonerow. Peter Wonerow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Florian, Peter, et al.. (2017). Anti-GPVI Fab SAR264565 effectively blocks GPVI function in ex vivo human platelets under arterial shear in a perfusion chamber. European Journal of Clinical Pharmacology. 73(8). 949–956. 12 indexed citations
2.
Steinmetz, Anke, François Vallée, Christian Beil, et al.. (2016). CODV-Ig, a universal bispecific tetravalent and multifunctional immunoglobulin format for medical applications. mAbs. 8(5). 867–878. 38 indexed citations
3.
Kozian, Detlef, et al.. (2012). Selective non-lipid modulator of LPA5 activity in human platelets. Bioorganic & Medicinal Chemistry Letters. 22(16). 5239–5243. 32 indexed citations
4.
Führer, Dagmar, Michael Mix, H Willgerodt, et al.. (2009). Autosomal dominant nonautoimmune hyperthyroidism Clinical features - diagnosis - therapy. Experimental and Clinical Endocrinology & Diabetes. 106(S 04). S10–S15. 1 indexed citations
5.
Senis, Yotis A., Ben Atkinson, Andrew C. Pearce, et al.. (2005). Role of the p110δ PI 3-kinase in integrin and ITAM receptor signalling in platelets. Platelets. 16(3-4). 191–202. 40 indexed citations
6.
Wonerow, Peter, Andrew C. Pearce, David J. Vaux, & Steve P. Watson. (2003). A Critical Role for Phospholipase Cγ2 in αIIbβ3-mediated Platelet Spreading. Journal of Biological Chemistry. 278(39). 37520–37529. 114 indexed citations
7.
Marshall, Stuart, Naoki Asazuma, Denise Best, et al.. (2002). Glycoprotein IIb-IIIa-dependent aggregation by glycoprotein Ibα is reinforced by a Src family kinase inhibitor (PP1)-sensitive signalling pathway. Biochemical Journal. 361(2). 297–297. 35 indexed citations
8.
Marshall, Stuart, Naoki Asazuma, Denise Best, et al.. (2002). Glycoprotein IIb-IIIa-dependent aggregation by glycoprotein Ibα is reinforced by a Src family kinase inhibitor (PP1)-sensitive signalling pathway. Biochemical Journal. 361(2). 297–305. 31 indexed citations
9.
Wonerow, Peter, et al.. (2002). Expression of G(alpha)(s) proteins and TSH receptor signalling in hyperfunctioning thyroid nodules with TSH receptor mutations. European Journal of Endocrinology. 147(1). 109–116. 17 indexed citations
10.
Wonerow, Peter, Achim Obergfell, Jonathan I. Wilde, et al.. (2002). Differential role of glycolipid-enriched membrane domains in glycoprotein VI- and integrin-mediated phospholipase Cγ2 regulation in platelets. Biochemical Journal. 364(3). 755–765. 79 indexed citations
11.
Wonerow, Peter & Steve P. Watson. (2001). The transmembrane adapter LAT plays a central role in immune receptor signalling. Oncogene. 20(44). 6273–6283. 21 indexed citations
12.
Wonerow, Peter, Susanne Neumann, Thomas Gudermann, & Reinhard Paschke. (2001). Thyrotropin receptor mutations as a tool to understand thyrotropin receptor action. Journal of Molecular Medicine. 79(12). 707–721. 31 indexed citations
13.
Wonerow, Peter, et al.. (2000). Functional characterization of five constitutively activating thyrotrophin receptor mutations. Clinical Endocrinology. 53(4). 461–468. 26 indexed citations
14.
Trülzsch, Barbara, et al.. (2000). Detection of thyroid-stimulating hormone receptor and Gs α mutations: in 75 toxic thyroid nodules by denaturing gradient gel electrophoresis. Journal of Molecular Medicine. 78(12). 684–691. 85 indexed citations
15.
Führer, Dagmar, et al.. (1999). Variable Phenotype Associated with Ser505Asn-Activating Thyrotropin-Receptor Germline Mutation. Thyroid. 9(8). 757–761. 31 indexed citations
16.
Wonerow, Peter, Torsten Schöneberg, Günter Schultz, Thomas Gudermann, & Ralf Paschke. (1998). Deletions in the Third Intracellular Loop of the Thyrotropin Receptor. Journal of Biological Chemistry. 273(14). 7900–7905. 65 indexed citations
17.
Holzapfel, H., Peter Wonerow, W. v. Petrykowski, et al.. (1997). Sporadic Congenital Hyperthyroidism due to a Spontaneous Germline Mutation in the Thyrotropin Receptor Gene*. The Journal of Clinical Endocrinology & Metabolism. 82(11). 3879–3884. 63 indexed citations
18.
Führer, Dagmar, et al.. (1997). Somatic Mutations in the Thyrotropin Receptor Gene and Not in the Gsα Protein Gene in 31 Toxic Thyroid Nodules. The Journal of Clinical Endocrinology & Metabolism. 82(11). 3885–3891. 94 indexed citations
19.
Führer, Dagmar, et al.. (1997). Identification of Constitutively Activating Somatic Thyrotropin Receptor Mutations in a Subset of Toxic Multinodular Goiters. The Journal of Clinical Endocrinology & Metabolism. 82(12). 4229–4233. 50 indexed citations
20.
Führer, Dagmar, Peter Wonerow, H Willgerodt, Ralf Paschke, & Dagmar Führer‐Sakel. (1997). Identification of a New Thyrotropin Receptor Germline Mutation (Leu629Phe) in a Family with Neonatal Onset of Autosomal Dominant Nonautoimmune Hyperthyroidism. The Journal of Clinical Endocrinology & Metabolism. 82(12). 4234–4238. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Consuelo González‐Manchón Breakdown of academic impact, for papers by J W Voss Breakdown of academic impact, for papers by Seema Mohamed Breakdown of academic impact, for papers by Angela Russo Breakdown of academic impact, for papers by Ruoqian Shen Breakdown of academic impact, for papers by Laura A. Maile Breakdown of academic impact, for papers by Mousumi Majumdar Breakdown of academic impact, for papers by Chenzhong Fu Breakdown of academic impact, for papers by Pavel N. Pichurin Breakdown of academic impact, for papers by M M Thompson
Rankless by CCL
2026